Aptose Biosciences is a science-driven biotechnology company advancing first-in-class agents to treat life-threatening cancers, such as acute myeloid leukemia (AML), high-risk myelodysplastic syndromes (MDS) and other hematologic malignancies. Based on insights into the genetic and epigenetic profiles of certain cancers and patient populations, Aptose is building a pipeline of novel...
Business Services,Biotechnology,Biotechnology Research,Biopharma,Oncology,Organizations,Education,Drug Discovery,Myelodysplastic Syndromes,Health Care,Acute Myeloid Leukemia,Science and Engineering,Hematology,Clinical Trials,Drug Development & Discovery,Apoptosis